^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MRDaccuPanel™ AML FLT3-ITD

Company:
NGeneBio
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
The FLT3-ITD test product (MRDaccuPanel™ AML FLT3-ITD) for acute myeloid leukemia (AML) micro-residual disease can detect the ITD of the FLT3 gene , which has a length that could not be detected by conventional methods, with higher sensitivity and accuracy than existing products, and at the same time, it can also identify mutations in the TKD (Tyrosine Kinase Domain) region.
Cancer:
Acute Myelogenous Leukemia
Gene:
FLT3 (Fms-related tyrosine kinase 3)
Method:
Liquid biopsy